Clinical Trial Update: Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating oral vitamin C for severity reduction of oral mucositis in patients undergoing chemoradiation for head and neck cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre | Conditions: Oral Mucositis | Phase 2, Phase 3 | Status: COMPLETED